Pier 88 Investment Partners LLC Ultragenyx Pharmaceutical Inc. Transaction History

Pier 88 Investment Partners LLC

  • $76.1 Million
  • Q3 2024

A detailed history of Pier 88 Investment Partners LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 22,540 shares of RARE stock, worth $996,718. This represents 1.65% of its overall portfolio holdings.

Number of Shares
22,540
Previous 25,970 13.21%
Holding current value
$996,718
Previous $1.07 Million 17.34%
% of portfolio
1.65%
Previous 1.23%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$40.21 - $59.36 $137,920 - $203,604
-3,430 Reduced 13.21%
22,540 $1.25 Million
Q2 2024

Aug 06, 2024
BUY
$37.42 - $51.61 $400,394 - $552,227
10,700 Added 70.07%
25,970 $1.07 Million
Q1 2024

May 10, 2024
SELL
$43.02 - $53.69 $228,866 - $285,630
-5,320 Reduced 25.84%
15,270 $712,000
Q4 2023

Feb 09, 2024
BUY
$31.73 - $49.19 $282,714 - $438,282
8,910 Added 76.28%
20,590 $984,000
Q3 2023

Nov 09, 2023
SELL
$34.92 - $46.66 $405,770 - $542,189
-11,620 Reduced 49.87%
11,680 $416,000
Q2 2023

Aug 07, 2023
BUY
$37.35 - $52.15 $57,892 - $80,832
1,550 Added 7.13%
23,300 $1.07 Million
Q4 2022

Feb 08, 2023
SELL
$33.72 - $46.33 $36,754 - $50,499
-1,090 Reduced 4.77%
21,750 $1.01 Million
Q3 2022

Nov 14, 2022
BUY
$39.96 - $66.14 $291,308 - $482,160
7,290 Added 46.88%
22,840 $946,000
Q4 2021

Feb 14, 2022
BUY
$73.71 - $87.86 $255,036 - $303,995
3,460 Added 28.62%
15,550 $1.31 Million
Q3 2021

Nov 12, 2021
BUY
$77.92 - $102.4 $391,548 - $514,560
5,025 Added 71.13%
12,090 $1.09 Million
Q2 2021

Aug 13, 2021
BUY
$92.19 - $115.71 $119,847 - $150,423
1,300 Added 22.55%
7,065 $673,000
Q1 2021

May 14, 2021
BUY
$106.9 - $167.73 $261,370 - $410,099
2,445 Added 73.64%
5,765 $656,000
Q4 2020

Feb 12, 2021
SELL
$84.4 - $177.39 $686,172 - $1.44 Million
-8,130 Reduced 71.0%
3,320 $1.51 Million
Q3 2020

Nov 16, 2020
SELL
$72.98 - $90.0 $369,643 - $455,850
-5,065 Reduced 30.67%
11,450 $941,000
Q2 2020

Aug 14, 2020
BUY
$46.91 - $78.22 $86,783 - $144,707
1,850 Added 12.62%
16,515 $1.29 Million
Q4 2019

Feb 14, 2020
BUY
$36.08 - $45.83 $62,779 - $79,744
1,740 Added 13.46%
14,665 $626,000
Q3 2019

Nov 14, 2019
BUY
$42.5 - $63.11 $108,800 - $161,561
2,560 Added 24.7%
12,925 $553,000
Q1 2019

May 15, 2019
BUY
$39.87 - $69.36 $121,603 - $211,548
3,050 Added 41.7%
10,365 $719,000
Q4 2018

Feb 11, 2019
BUY
$38.89 - $77.3 $10,500 - $20,871
270 Added 3.83%
7,315 $318,000
Q3 2018

Nov 14, 2018
BUY
$71.81 - $90.15 $89,403 - $112,236
1,245 Added 21.47%
7,045 $538,000
Q2 2018

Jul 25, 2018
BUY
$48.54 - $85.31 $281,532 - $494,798
5,800 New
5,800 $446,000

Others Institutions Holding RARE

# of Institutions
325
Shares Held
85.6M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.1B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Pier 88 Investment Partners LLC Portfolio

Follow Pier 88 Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier 88 Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier 88 Investment Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email